Sustained asthma control and remission in real-world patients with severe eosinophilic asthma receiving benralizumab: XALOC-2

Marek Lommatzsch, Erika Penz, Lieven Dupont, Trung N. Tran, Andrew Menzies-Gow, Anat Shavit, David Cohen, Tanja Plate, Mackenzie A. Hamilton, Charlotte Quataert, Claudio Schuoler, Thomas Rothe, Benjamin Emmanuel

Open source

DOI: 10.1080/02770903.2026.2696569
Published: 2026-07-04
Container: Journal of Asthma
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/02770903.2026.2696569,
  title = {Sustained asthma control and remission in real-world patients with severe eosinophilic asthma receiving benralizumab: XALOC-2},
  author = {Marek Lommatzsch and Erika Penz and Lieven Dupont and Trung N. Tran and Andrew Menzies-Gow and Anat Shavit and David Cohen and Tanja Plate and Mackenzie A. Hamilton and Charlotte Quataert and Claudio Schuoler and Thomas Rothe and Benjamin Emmanuel},
  year = {2026},
  journal = {Journal of Asthma},
  doi = {10.1080/02770903.2026.2696569},
  url = {https://doi.org/10.1080/02770903.2026.2696569}
}

RIS

TY  - JOUR
TI  - Sustained asthma control and remission in real-world patients with severe eosinophilic asthma receiving benralizumab: XALOC-2
AU  - Marek Lommatzsch
AU  - Erika Penz
AU  - Lieven Dupont
AU  - Trung N. Tran
AU  - Andrew Menzies-Gow
AU  - Anat Shavit
AU  - David Cohen
AU  - Tanja Plate
AU  - Mackenzie A. Hamilton
AU  - Charlotte Quataert
AU  - Claudio Schuoler
AU  - Thomas Rothe
AU  - Benjamin Emmanuel
PY  - 2026
JO  - Journal of Asthma
DO  - 10.1080/02770903.2026.2696569
UR  - https://doi.org/10.1080/02770903.2026.2696569
ER  -

APA

Lommatzsch, M., Penz, E., Dupont, L., Tran, T. N., Menzies-Gow, A., Shavit, A., Cohen, D., Plate, T., Hamilton, M. A., Quataert, C., Schuoler, C., Rothe, T., & Emmanuel, B. (2026). Sustained asthma control and remission in real-world patients with severe eosinophilic asthma receiving benralizumab: XALOC-2. Journal of Asthma. https://doi.org/10.1080/02770903.2026.2696569

Source records

crossref · retrieved 2026-09-25T19:31:31.360Z